Vascular Effects of Triglyceride-rich Lipoproteins
Fjalë kyçe
Abstrakt
Datat
Verifikuar së fundmi: | 08/31/2019 |
Paraqitur së pari: | 06/07/2012 |
Regjistrimi i vlerësuar u dorëzua: | 06/10/2012 |
Postuar së pari: | 06/12/2012 |
Përditësimi i fundit i paraqitur: | 09/11/2019 |
Përditësimi i fundit i postuar: | 09/15/2019 |
Data e fillimit të studimit aktual: | 05/31/2012 |
Data e vlerësuar e përfundimit primar: | 09/30/2012 |
Data e vlerësimit të përfundimit të studimit: | 09/30/2012 |
Gjendja ose sëmundja
Ndërhyrja / trajtimi
Dietary Supplement: High-fat meals varying in their fatty acid composition
Faza
Grupet e krahëve
Krah | Ndërhyrja / trajtimi |
---|---|
Active Comparator: Oleic acid 75 g high oleic acid sunflower oil. | |
Active Comparator: Linoleic acid 75 g high linoleic acid sunflower oil. | |
Experimental: Eicosapentaenoic acid and docosahexaenoic acid 5 g EPA and DHA derived from fish oil, made up to a total of 75 g with high oleic sunflower oil. | |
Experimental: Docosahexaenoic acid 5 g DHA derived from algal oil, made up to a total of 75 g with high oleic sunflower oil. |
Kriteret e pranimit
Moshat e pranueshme për studim | 35 Years Për të 35 Years |
Gjinitë e pranueshme për studim | Male |
Pranon Vullnetarë të Shëndetshëm | po |
Kriteret | Inclusion Criteria: - Healthy males - Non-smokers - Aged 35-70 years - Fasting TAG concentrations ≥1.2 mmol/L. Exclusion Criteria: - Reported history of CVD (myocardial infarction, angina, venous thrombosis, stroke), impaired fasting glucose/uncontrolled type 2 diabetes (or fasting glucose ≥ 6.1 mmol/L), cancer, kidney, liver or bowel disease. - Presence of gastrointestinal disorder or use of drug, which is likely to alter gastrointestinal motility or nutrient absorption. - History of substance abuse or alcoholism (previous weekly alcohol intake >60 units/men) - Current self-reported weekly alcohol intake exceeding 28 units - Allergy or intolerance to any component of test meals - Unwilling to restrict consumption of any source of fish oil for the length of the study - Weight change of >3kg in preceding 2 months - Body Mass Index <20 and >35 kg/m2 - Fasting blood cholesterol > 7.8 mmol/L - Current cigarette smoker. - Current use of lipid lowering medication |
Rezultati
Masat Kryesore të Rezultateve
1. Activation of inflammatory/oxidative stress pathways within cultured endothelial cells following treatment with 6 h postprandial chylomicron remnant-rich lipoprotein fraction [6 h post-meal]
Masat dytësore të rezultateve
1. Incremental area under the plasma concentration versus time curve (iAUC) of triacylglycerol [0, 1, 2, 3, 4, 5 and 6 h post-meal]
2. Incremental area under the plasma concentration versus time curve (iAUC) of glucose [0, 1, 2, 3, 4, 5 and 6 h post-meal]
3. Incremental area under the plasma concentration versus time curve (iAUC) for non-esterified fatty acids [0, 1, 2, 3, 4, 5 and 6 h post-meal]
4. Incremental area under the plasma concentration versus time curve (iAUC) for plasma fatty acid composition (%) [0, 1, 2, 3, 4, 5 and 6 h post-meal]
5. Incremental area under the plasma concentration versus time curve (iAUC) for cholesterol [0, 1, 2, 3, 4, 5 and 6 h post-meal]
6. Incremental area under the unit measure versus time curve for brachial augmentation index [0, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330 and 360 min post-meal]
7. Incremental area under the unit measure versus time curve for systolic blood pressure [0, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330 and 360 min post-meal]
8. Incremental area under the unit measure versus time curve for diastolic blood pressure [0, 30, 60, 90, 120, 150, 180, 210, 240, 270, 300, 330 and 360 min post-meal]
9. Change in digital volume pulse stiffness index [0, 2, 4 and 6 h post-meal]
10. Change in digital volume pulse reflection index [0, 2, 4 and 6 h post-meal]
11. Change in plasma nitrite/nitrate concentrations [0, 2, 4 and 6 h]
12. Change in plasma 8-isoprostane F2alpha concentrations [0, 2, 4 and 6 h post-meal]
13. Activation of inflammatory/oxidative stress pathways within cultured endothelial cells following treatment with 4 h postprandial chylomicron remnant-rich lipoprotein fraction [4 h post-meal]
14. Activation of inflammatory/oxidative stress pathways within cultured endothelial cells following treatment with 5 h postprandial chylomicron remnant-rich lipoprotein fraction [5 h post-meal]